Virion Therapeutics, LLC — Form D/A

Virion Therapeutics, LLC of NEWARK, DE, a company, filed a Form D amendment with the SEC on 2021-10-07. The offering totals $6.0M, of which $5.7M was reported sold. Industry: Biotechnology.

Offering

Filed: 2021-10-07
Form: D/A
Accession: 0001746726-21-000009
Industry: Biotechnology
Exemptions: 06b
Total offering: $6.0M
Amount sold: $5.7M
Remaining: $330K
Minimum investment: $25K
Investors: 49
Date of first sale: 2019-10-28
Security types: debt
Revenue range: No Revenues
SEC file number: 021-352490

Issuer

Name: Virion Therapeutics, LLC
CIK: 0001746726
Entity type: Limited Liability Company
Jurisdiction: DELAWARE
Incorporated: 2018
Address: 7 CREEK BEND COURT, NEWARK, DE, 19711
Phone: 800-841-9303

Officers, directors & promoters (4)

Name	Role	Location
Andrew Luber	Director	Newark, DE
Bernard Rudnick	Director	Newark, DE
Andrew Luber	Executive Officer	Newark, DE
Bernard Rudnick	Executive Officer	Newark, DE

Other filings by this issuer (24)

Showing 15 of 24 filings.

Filed	Form	Offering	Sold
2021-08-25	D/A	$6.0M	$3.9M
2021-08-11	D/A	$6.0M	$3.4M
2021-06-08	D/A	$6.0M	$3.1M
2021-05-13	D/A	$6.0M	$3.0M
2021-03-12	D/A	$6.0M	$2.8M
2021-02-24	D/A	$6.0M	$1.9M
2021-01-21	D/A	$6.0M	$1.2M
2021-01-04	D/A	$6.0M	$1.1M
2020-11-05	D/A	$6.0M	$1.3M
2020-10-20	D/A	$6.0M	$1.1M
2020-09-17	D/A	$6.0M	$960K
2020-08-13	D/A	$6.0M	$695K
2020-07-28	D/A	$6.0M	$595K
2020-05-20	D/A	$6.0M	$545K
2020-03-18	D/A	$6.0M	$695K

More